REDUCED MORBIDITY FROM SKELETAL METASTASES IN BREAST CANCER PATIENTS DURING LONG-TERM BISPHOSPHONATE (APD) TREATMENT

The Lancet

Volumn 330, Issue 8566, 1987, Pages 983-985

  van Holten Verzantvoort, A Th ^a,b,c   Bijvoet, O L M ^a,b,c   Hermans, J ^a,b,c   Harinck, H I J ^a,b,c   Elte, J W F ^a,b,c   Beex, L V A M ^a,b,c   Cleton, F J ^a,b,c   Kroon, H M ^a,b,c   Vermey, P ^a,b,c   Neijt, J P ^a,b,c   Blijham, G ^a,b,c  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PAMIDRONIC ACID;

BONE; BONE PAIN; BREAST; BREAST CANCER; CONTROLLED STUDY; HUMAN; HYPERCALCEMIA; MAJOR CLINICAL STUDY; METASTASIS; THERAPY;

ADULT; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; BREAST NEOPLASMS; CLINICAL TRIALS; DIPHOSPHONATES; FEMALE; FOLLOW-UP STUDIES; FRACTURES, SPONTANEOUS; HUMAN; HYPERCALCEMIA; LONG-TERM CARE; MIDDLE AGE; NAUSEA; OSTEOLYSIS; PAIN; PROSPECTIVE STUDIES; RANDOM ALLOCATION; SUPPORT, NON-U.S. GOV'T; TABLETS, ENTERIC-COATED;

EID: 0023200599     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(87)92555-4     Document Type: Article

References (18)

1. Osteolytic bone metastasis in breast carcinoma Pathogenesis, morbidity and bisphosphonate treatment
2. The role of bone and kidney in tumour hypercalcemia and its treatment with bisphosphonate and sodium chloride
3. Comparative study of available medical therapy for hypercalcemia of malignancy
4. Companson of two parenteral diphosphonates in hypercalcemia of malignancy
5. Place des diphosphonates dans let thérapeutique de l'ostéolyse et des hypercalcémies malignes
6. Two modes of action of bisphosphonates on osteolytic resorption of mineralized bone matrix
7. Bisphosphonates. Mechanism of action and clinical applications
8. A new bisphosphonate: Dissociation between effects on cells and mineral in rats and a preliminary trial in Paget's disease
9. Inhibition of osteolytic bone lesions by (3-amino, 1-hydroxypropylidene)-1, 1-bisphosphonate (A.P.D
10. Long-term controlled trial with diphosphonate in patients with osteolytic bone metastases
11. Assessment of response to therapy in advanced breast cancer
12. Efficaceous management with APD in Paget's disease of bone
13. Charactectistics and bisphosphonate treatment of a patient with juvenile osteoporosis
14. Companson of intravenous (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate and volume repletion in tumour-induced hypercalcaemia
15. Diphosphonates for osteolytic metastases
16. Use of dichloromethylene diphosphonate in metastatic bone disease
17. Effects of dichloromethylene diphosphonate in women with breast carcinoma, metastatic to the skeleton
18. Enhancement of the inhibitory action of APD on the transformation of osteoclast precursors into resorbing cells after dimethylation of the ammo group